関連する実験動画
Updated: Jul 12, 2026

06:41
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
血液形成幹細胞は染色体を非対称的に分離したり,BrdUを保持したりしません
Mark J Kiel1, Shenghui He, Rina Ashkenazi
1Howard Hughes Medical Institute, Life Sciences Institute, Department of Internal Medicine, and Centre for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109-2216, USA.
Nature
|August 31, 2007
まとめ
血液形成性幹細胞 (HSC) は,BrdUのようなDNAラベルを保持せず,不死の鎖仮説に異議を唱える. これらの幹細胞は不対称ではなくランダムに分裂し,BrdUはそれらを識別するための信頼性の低いマーカーです.
科学分野:
- 幹細胞生物学 幹細胞生物学とは
- 分子遺伝学 分子遺伝学
- ヘマトポエーシス (血液形成) とは
背景:
- "不死鎖仮説"は,幹細胞における非対称なDNA鎖分離を提唱している.
- 幹細胞は,より古いDNA鎖を保持し,DNAラベル保持 (例えば,BrdU) につながると考えられています.
- この仮説は,決定的な幹細胞マーカーを持つシステムでは検証が欠けている.
研究 の 目的:
- 超浄化血球形成幹細胞 (HSC) で不死鎖仮説を検証する.
- HSCのマーカーとしてBrdU保持の信頼性を評価する.
- HSCにおけるDNA分離パターンを決定する.
主な方法:
- BrdUを様々な条件下でマウスに投与し,その後追跡期間を設けました.
- 精製されたHSCにおける評価されたBrdU保持量.
- DNA分離を分析するために,連続的なBrdUラベリングと単細胞培養を用いた.
主要な成果:
- HSCの6%未満がBrdUを保持し,BrdUを保持する細胞の<0.5%がHSCであり,マーカーの特異性/敏感性が低いことを示しています.
- HSCはランダムな染色体分離を示したが,非対称的な分離を示さなかった.
- 試験管培養では,個々のHSCで非対称なラベル分離が認められなかった.
結論:
- BrdU保持は,HSCを特定するための信頼できる方法ではありません.
- HSCは非対称なDNA鎖分離を示さない.
- 不死鎖仮説は,HSCの一般的な特性ではない.
関連する概念動画
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency and Niche of Bulge Stem Cell
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

